Nanomaterials in Medical Devices: Regulations' Review and Future Perspectives
This article gives a brief description of the existing regulations related to biomaterials safety that need to be considered before it is introduced into EU market. According to these regulations, the risk analysis should include two characteristics: probability of occurrence of harm, and severity. Identified user-related harm should be reduced by managing the risk. Additionally, the review presents an overview of engineered biomaterials (EBMs), which in combination with nanoscale components (NPs) have shown promises in Advanced Therapy Medicinal Products (ATMP) and Medical Devices (MD). In this article, recent challenges, objectives and perspectives in risk assessment and risk management of ATMP and MD composed of nanobiomaterials were also highlighted.
Year of publication: |
2017
|
---|---|
Authors: | Jagiello, Karolina ; Sosnowska, Anita ; Mikolajczyk, Alicja ; Puzyn, Tomasz |
Published in: |
Journal of Nanotoxicology and Nanomedicine (JNN). - IGI Global, ISSN 2379-7444, ZDB-ID 2860097-6. - Vol. 2.2017, 2 (01.07.), p. 1-11
|
Publisher: |
IGI Global |
Subject: | Advanced Therapy Medicinal Products | Engineering Nanomaterials | EU Regulations | Medical Devices | Nano-Bio-Materials | Risk Assessment | Risk Management | Safety Assessment |
Saved in:
Online Resource
Saved in favorites
Similar items by subject
-
Quasi-SMILES for Nano-QSAR Prediction of Toxic Effect of Al2O3 Nanoparticles
Toropova, Alla P., (2016)
-
Havlová, Vaclava, (2014)
-
Günther, Elmar, (2009)
- More ...